| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −4.8× | −1.8× | |
| Price / Book | −39.1× | 2.1× | |
| Price / Sales | 2.1× | 4.0× | |
| Price / Free cash flow | −8.1× | −1.6× | |
| EV / EBITDA | −5.9× | −1.1× | |
| Earnings yield | −20.9% | −14.0% | |
| Free cash flow yield | −12.4% | −9.5% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,283.92 | −1.74% | $1.21T | 59.6× | 77.8% | +21.1% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $263.70 | −1.46% | $634.81B | 24.0× | 32.9% | +39.5% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $283.88 | −0.46% | $501.65B | 119.3× | −129.2% | +23.3% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $421.77 | −0.76% | $378.58B | 31.6× | 12.8% | +16.3% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.41 | −1.92% | $356.28B | 19.9× | 34.7% | +68.0% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $155.54 | −0.47% | $280.28B | 20.0× | 30.5% | +19.0% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $170.82 | −1.01% | $264.93B | 26.1× | 21.1% | +3.3% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $673.61 | −0.43% | $249.07B | 37.1× | 12.6% | +21.2% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $442.10 | −1.16% | $239.01B | 31.4× | 89.1% | +48.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $157.14 | −0.03% | $194.85B | 22.9× | 37.5% | +26.7% |
